Holen Sie sich die Stockscreener-App
1.72
11.79%
-0.23
Schlusskurs vom Vortag:
$1.95
Offen:
$1.9
24-Stunden-Volumen:
121.92K
Relative Volume:
0.86
Marktkapitalisierung:
$45.91M
Einnahmen:
$48.20M
Nettoeinkommen (Verlust:
$-35.05M
KGV:
-1.0974
EPS:
-1.5673
Netto-Cashflow:
$-13.02M
1W Leistung:
-17.70%
1M Leistung:
-19.25%
6M Leistung:
+7.84%
1J Leistung:
+19.44%
1-Tages-Spanne:
$1.70
$1.90
1-Wochen-Bereich:
$1.70
$2.06
52-Wochen-Spanne:
$1.06
$5.22
Celularity Inc Stock (CELU) Company Profile
Firmenname
Celularity Inc
Sektor
Branche
Telefon
(908) 768-2170
Adresse
170 PARK AVE, FLORHAM PARK
Vergleichen Sie CELU mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CELU
Celularity Inc
|
1.72 | 52.05M | 48.20M | -35.05M | -13.02M | -1.5673 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Celularity Inc Stock (CELU) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-30 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-12-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-06-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-04-06 | Herabstufung | Truist | Buy → Hold |
| 2022-01-28 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-24 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Celularity Inc Aktie (CELU) Neueste Nachrichten
Chart based analysis of Celularity Inc. Equity Warrant trendsIPO Watch & Real-Time Chart Pattern Alerts - newser.com
Quantitative breakdown of Celularity Inc. Equity Warrant recent moveJuly 2025 Selloffs & Safe Entry Momentum Tips - newser.com
DefEYE and Celularity partner to advance ophthalmic biologics portfolios - Eyes On Eyecare
Backtesting results for Celularity Inc. trading strategiesJuly 2025 Final Week & Reliable Volume Spike Trade Alerts - newser.com
How to monitor Celularity Inc. with trend dashboardsJuly 2025 Macro Moves & Entry Point Confirmation Signals - newser.com
Celularity Inc. Equity Warrant stock trendline breakdownTrade Analysis Report & Momentum Based Trading Ideas - newser.com
Published on: 2025-11-03 06:09:03 - newser.com
Should you wait for a breakout in Celularity Inc.2025 Risk Factors & Growth-Oriented Investment Plans - newser.com
Is Celularity Inc. Equity Warrant stock attractive for long term wealth buildingM&A Rumor & AI Driven Stock Reports - newser.com
Is Celularity Inc. Equity Warrant stock entering bullish territory2025 Trading Volume Trends & Community Verified Swing Trade Signals - newser.com
Statistical indicators supporting Celularity Inc.’s strengthShare Buyback & Technical Entry and Exit Tips - newser.com
How Celularity Inc. stock performs during Fed tightening cyclesDip Buying & Daily Market Momentum Tracking - newser.com
Has Celularity Inc. Equity Warrant formed a bullish divergence2025 Valuation Update & Fast Exit and Entry Trade Guides - newser.com
How to interpret RSI for Celularity Inc. Equity Warrant stockTrade Risk Summary & Risk Controlled Stock Pick Alerts - newser.com
What does recent volatility data suggest for Celularity Inc.Weekly Market Outlook & Stock Portfolio Risk Control - newser.com
Strategies to average down on Celularity Inc. Equity WarrantInflation Watch & Technical Pattern Alert System - newser.com
Can Celularity Inc. Equity Warrant stock beat market expectations this quarterJuly 2025 Big Picture & Safe Capital Growth Trade Ideas - newser.com
Candlestick signals on Celularity Inc. stock todayGDP Growth & Weekly Chart Analysis and Guides - newser.com
Why Celularity Inc. stock is a value investor pickJuly 2025 Setups & Expert-Curated Trade Recommendations - newser.com
Will Celularity Inc. Equity Warrant stock benefit from infrastructure spendingTrade Exit Report & Consistent Profit Trading Strategies - newser.com
Historical volatility pattern of Celularity Inc. visualizedTrade Signal Summary & Consistent Profit Trade Alerts - newser.com
Applying big data sentiment scoring on Celularity Inc. Equity WarrantGold Moves & Real-Time Stock Entry Alerts - newser.com
How to escape a deep drawdown in Celularity Inc. Equity WarrantPortfolio Risk Summary & Growth Focused Stock Reports - newser.com
What analysts say about Celularity Inc stockPrice Volatility Patterns & Subscribe for Free Weekly Winners - earlytimes.in
What technical models suggest about Celularity Inc. Equity Warrant’s comeback2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
Detecting support and resistance levels for Celularity Inc. Equity WarrantMarket Trend Report & AI Optimized Trading Strategy Guides - newser.com
Is Celularity Inc. stock a safe investment in uncertain marketsWeekly Trade Recap & Free Low Drawdown Momentum Trade Ideas - newser.com
Can Celularity Inc. Equity Warrant stock sustain market leadershipJuly 2025 Price Swings & Verified Momentum Stock Watchlist - newser.com
Why Celularity Inc. Equity Warrant stock remains on buy listsDip Buying & Risk Controlled Stock Alerts - newser.com
Published on: 2025-11-02 01:15:33 - newser.com
Is Celularity Inc. Equity Warrant stock supported by strong cash flowsJuly 2025 PostEarnings & Precise Buy Zone Identification - newser.com
Analyzing Celularity Inc. with multi timeframe chartsJuly 2025 Review & Daily Chart Pattern Signals - newser.com
Finanzdaten der Celularity Inc-Aktie (CELU)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):